Skip to main content

Syndicate contentNew York

Ben-Gurion University Alzheimer's researcher demonstrates specific immune response to vaccine

BEER-SHEVA, September, 21 2009 -- A researcher who is working on a vaccine for Alzheimer's disease (AD) has demonstrated that it is possible to test and measure specific immune responses in mice carrying human genes and to anticipate the immune response in Alzheimer's patients.

New genetic link between cardiac arrhythmias and thyroid dysfunction identified

NEW YORK (September 20, 2009) -- Genes previously known to be essential to the coordinated, rhythmic electrical activity of cardiac muscle -- a healthy heartbeat -- have now also been found to play a key role in thyroid hormone (TH) biosynthesis, according to Weill Cornell Medical College researchers.

Mount Sinai first in nation to ablate atrial fibrillation using new visually-guided balloon catheter

Physicians at The Mount Sinai Medical Center in New York became the first in the U.S. to ablate atrial fibrillation using a visually-guided laser balloon catheter. The procedure was performed September 15 by Vivek Y. Reddy, MD, Professor of Medicine and Director of the Cardiac Arrhythmia Service at Mount Sinai Heart, and his colleague, Srinivas R.

Weill Cornell researchers discover new antituberculosis compounds

NEW YORK (September 16, 2009) -- Attempts to eradicate tuberculosis (TB) are stymied by the fact that the disease-causing bacteria have a sophisticated mechanism for surviving dormant in infected cells. Now, a team of scientists led by researchers from Weill Cornell Medical College has identified compounds that inhibit that mechanism -- without damaging human cells.

Oxygen-saturated blood reduces levels of damaged heart tissue following a heart attack

NEW YORK -- SEPTEMBER 15, 2009 -- Results of a clinical trial published today in Circulation: Cardiovascular Interventions demonstrate that an infusion of blood that is "supersaturated" with oxygen (SS02) can reduce the amount of damaged heart muscle immediately following a life-threatening heart attack.

Two treatment innovations improve heart function after heart attack

Supersaturated oxygen (SSO2) administered during catheter-based treatments for heart attack can significantly reduce heart muscle damage, according to a new study reported in Circulation: Cardiovascular Interventions, a journal of the American Heart Association.

In another study from the same issue, a different group of researchers found that manually removing a blood clot provided greater

CU-Boulder team identifies DNA "barcodes to help track illegal trading of wildlife products

Researchers from several institutions including the University of Colorado at Boulder have sequenced DNA "barcodes" for as many as 25 hunted wildlife species, providing information that can be used to better monitor the elusive trade of wildlife products, or bushmeat.

Tuberculosis patients can reduce transmissability by inhaling interferon through a nebulizer

New York, NY (September 14, 2009): A new study published in the September 15, 2009, issue of PLoS ONE found that patients with cavitary pulmonary tuberculosis receiving anti-TB medications supplemented with nebulized interferon-gamma have fewer bacilli in the lungs and less inflammation, thereby reducing the transmissibility of tuberculosis in the early phase of treatment.

Study identifies which children do not need CT scans after head trauma

A substantial percentage of children who get CT scans after apparently minor head trauma do not need them, and as a result are put at increased risk of cancer due to radiation exposure.

Daily bathroom showers may deliver face full of pathogens, says CU-Boulder study

While daily bathroom showers provide invigorating relief and a good cleansing for millions of Americans, they also can deliver a face full of potentially pathogenic bacteria, according to a surprising new University of Colorado at Boulder study.

Information about the use and accuracy of breast cancer tests is lacking, study finds

A new study finds that there is little information available about the use of new testing technologies and targeted therapies in breast cancer, specifically the anti-cancer drug trastuzumab (Herceptin).

Scientists discover mechanism to make existing antibiotics more effective at lower doses

New York, NY (September 10, 2009): A new study published in the September 11, 2009 issue of Science by researchers at the NYU School of Medicine reveals a conceptually novel mechanism that plays an important role in making human pathogens like Staphylococcus aureus and Bacillus anthracis resistant to numerous antibiotics. The study led by Evgeny A.

As ash borer claims more trees, researcher at ISU works for species survival

AMES, Iowa - Mark Widrlechner may someday be known as the modern-day Johnny Appleseed for ash trees.

As the devastating insect emerald ash borer is working its way across North America destroying almost all the native ash trees it encounters, Widrlechner is rapidly collecting and storing ash tree seeds.

Is inhibition a measure of free will?

September 9, 2009 by The Quantum Lob...

The Quantum Lobe Chronicles's picture

Reading Alwyn Scott's "Stairway to the Mind" I came across an interesting tidbit of information pointing out that human's have a greater percentage of inhibitory neurons compared to other animals (human 75% rabbit 31%). For some unknown reason this made me think about the tricky construct of free will and the question of whether free will could be better measured not by what we chose to do, but by what we chose not to do. In other words, could free will be measured by a capacity to inhibit certain thoughts and behaviors.

New type of adult stem cells found in the prostate may be involved in prostate cancer development

NEW YORK -- A new type of stem cell discovered in the prostate of adult mice can be a source of prostate cancer, according to a new study by researchers at the Herbert Irving Comprehensive Cancer Center at Columbia University Medical Center and NewYork-Presbyterian Hospital.



About us

Science Blog was started in August 2002. It lives, breathes and eats press releases from research organizations around the globe. Most of what you read here are press releases from the outfits named in the stories themselves. Got a news story you think belongs here? Let's talk. The other half of the equation is blog posts from readers like you. So if you have an interest in science, please register and join others like you in an ongoing, vibrant dialog about what makes the world tick. Meantime, please take a minute to read our Privacy Policy and Site Disclaimer.


Premium Drupal Themes by Adaptivethemes